Michael Pfreundschuh

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg et al. · The Lancet Oncology · 2006 · 2.1K citations

Medicine, Oncology, Chemotherapy +11

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy, Chip Stewart, Andrew Dunford et al. · Nature Medicine · 2018 · 2K citations · Full text

Medicine, Hematology, Oncology +12

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Yao‐Tseng Chen, Matthew J. Scanlan, Uğur Şahin et al. · Proceedings of the National Academy of Sciences · 1997 · 1.2K citations

Medicine, Molecular Biology, Oncology +17

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Medicine, Immunology, Oncology +7

Human neoplasms elicit multiple specific immune responses in the autologous host.

Uğur Şahin, Ö. Türeci, Holger Schmitt et al. · Proceedings of the National Academy of Sciences · 1995 · 1.1K citations

Medicine, Immunology, Oncology +17